NVS

Novartis AG (NVS)

Last Price$109.41.9%
Market Cap$217.3B
LTM FCF to Net Income
115.6%
5Y avg
124.8%
Drug Manufacturers - General industry median
88.5%
Stock quality & Intrinsic value
7/10
0.2% undervalued

Novartis AG FCF to Net Income

Annual
Quarterly
LTM
Industry median
Company stand-alone
NVS
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
FCF to Net Income
106.4%
91.0%
92.9%
91.3%
111.9%
118.7%
129.0%
113.2%
101.2%
95.0%
114.5%
128.3%
128.2%
86.5%
159.1%
137.1%
50.4%
166.3%
136.5%
115.6%
NVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NVS and see if it's the right time to invest.
Dive in

Novartis AG (NVS) FCF to Net Income comparison analysis

Crunching data... Almost there!

NVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Novartis AG's FCF to Net Income?

As of today, Microsoft Corp's last 12-month FCF to Net Income is 115.6%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual FCF to Net Income for Novartis AG have been 114.1% over the past three years, and 131.1% over the past five years.

2) Is Novartis AG's FCF to Net Income Good?

As of today, Novartis AG's FCF to Net Income is 115.6%, which is higher than industry median of 88.5%. It indicates that Novartis AG's FCF to Net Income is Good.

3) How does Novartis AG's FCF to Net Income compare to its peers?

As of today, Novartis AG's FCF to Net Income is 115.6%, which is higher than peer median of 69.4%. The list of peers includes ABBV, AMGN, JNJ, MRK, AZN, PFE, LLY, SNY, BMY, GILD.